Coronary heart disease is the most common type of heart disease, and the major cause of heart attacks. Epi+Gen CHD™ is a patent-pending Next Generation test that assesses your near-term (3-year) risk for a heart attack. It is the first and only clinical test for coronary heart disease primary prevention that provides personalized insights based on two types of DNA biomarkers unique to you – genetic and epigenetic.
resume writers association essay about consumer culture cialis online free shipping get link levitra villano beach https://eventorum.puc.edu/usarx/comprar-viagra-amazon/82/ creative writing skills powerpoint presentation go essay self evaluation sample how before levitra works pic of a sister doing homework good conclusion paragraphs compare contrast essays http://belltower.mtaloy.edu/studies/tok-essays-may-2009/20/ https://chanelmovingforward.com/stories/government-resume-help/51/ https://campuschildcare-old.wm.edu/thinking/the-essay-on-man-analysis/10/ acquisto sicuro levitra 20 click application essay questions thesis theme for powerpoint follow site financial management homework help essay on winter morning in gujarati https://goodbelly.com/rxpack/donde-puedo-comprar-cialis-en-usa/32/ hyperthermia seroquel kiedy viagra nie dziaa cialis online espaa does potassium chloride interact well with crestor essay globalization advantages disadvantages review related literature thesis cow essay wikipedia https://tetratherapeutics.com/treatmentrx/buy-viagra-200-mg/34/ thesis statement gmo Understanding your risk is the first step toward prevention. Take control of your heart health today!
Epi+Gen CHD™ has to be ordered by a clinician. You can request the test from one of our telemedicine providers by filling out a simple, five-minute assessment to determine your eligibility for this test. Once the test report is ready, you can schedule a telemedicine consultation with the clinician to review your risk score.
Take the Epi+Gen CHD™ test in the comfort and privacy of your own home, whenever you want. After your request is approved by a clinician, simply collect your blood sample using the kit that we will mail to you, and send it back to us in a prepaid package. Once your sample is processed, your report is only shared with you and your prescribing clinician, and we are compliant with all applicable regulations, such as HIPAA.
Our evidence-based, patent-pending DNA test is not just another genetic test. In addition to your genetics, this DNA test also measures your epigenetic biomarkers which are very important because they are influenced by your environment and lifestyle. Together, your genetic and epigenetic biomarkers provide a more holistic estimate of your three-year risk for a heart attack.
We analyze your unique DNA biomarker information through our proprietary Artificial Intelligence algorithms to determine, with high sensitivity, your likelihood of having a heart attack in the next 3 years. This risk estimate is reviewed by a clinician who will help tailor your personalized prevention plan.
It is not appropriate for those who:
Fill out a simple eligibility questionnaire that will be reviewed by an elicity clinician, without the need for an office visit.
Upon clinician approval, a step-by-step blood sample collection kit will be sent to your home. Send your sample to our CLIA lab using the prepaid return mailer included in your kit.
Once the test and analysis are complete, your risk score and prevention insights will be shared with the ordering clinician.
Register with elicity to access your results, and discuss your results and prevention insights with the clinician who ordered your test.